Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v31-FR Version v31-FR
Language French French
Date Updated 2024-01-08 2024-01-08
Drug Identification Number 02330288 02330288
Brand name TEVA-TELMISARTAN HCTZ TEVA-TELMISARTAN HCTZ
Common or Proper name TEVA-TELMISARTAN HCTZ TEVA-TELMISARTAN HCTZ
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients HYDROCHLOROTHIAZIDE TELMISARTAN HYDROCHLOROTHIAZIDE TELMISARTAN
Strength(s) 12.5MG 80MG 12.5MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 10 10
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-06-19 2023-06-19
Estimated end date 2023-12-20 2023-12-20
Actual end date 2023-12-21 2023-12-21
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments